Horan Capital Advisors, Llc. Gilead Sciences, Inc. Transaction History

Horan Capital Advisors, Llc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $89,507 - $101,989	-1,580 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$62.1 - $78.08 $98,118 - $123,366	1,580 New	1,580 $100,000
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $65,448 - $83,829	-1,045 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $65,322 - $72,105	1,045 New	1,045 $66,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $70,531 - $79,093	-1,140 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$62.53 - $70.05 $71,284 - $79,857	1,140 New	1,140 $74,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $126,647 - $148,665	-1,780 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $128,355 - $152,136	1,780	1,780 $144,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Horan Capital Advisors, Llc. with notifications on news.